| Issue |
BIO Web Conf.
Volume 121, 2024
Global Summit on Life Sciences and Bio-Innovation: From Agriculture to Biomedicine (GLSBIA 2024)
|
|
|---|---|---|
| Article Number | 03001 | |
| Number of page(s) | 6 | |
| Section | Cutting-edge Biomedicine and Pharmacological Discoveries | |
| DOI | https://doi.org/10.1051/bioconf/202412103001 | |
| Published online | 22 July 2024 | |
Content analysis of anticancer drugs of the pharmaceutical market of the republic of Uzbekistan
1 The Department of Farmacology, Bukhara state medical Institute, Bukhara, Uzbekistan
2 The Department of Clinical Sciences, Asian International University, Bukhara, Uzbekistan
* Corresponding author: shoxistaxon93@gmail.com
In the article, the analysis of anti-cancer drugs: 2018 №22, 2019 №23, 2020 №24, 2021 №25, 2022 №26 in the Republic of Uzbekistan according to the State Registers of drugs and medical products and drug forms was carried out. The results of the distribution of the dynamics of penetration of anticancer drugs into the pharmaceutical market by producing countries are presented. From this article, we can conclude that although the production of anti-cancer drugs has increased in the Republic of Uzbekistan in recent years, the number of drugs imported from abroad and the Commonwealth of Independent States has also increased.
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.